These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2419679)

  • 21. Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias.
    Anastasiou-Nana MI; Menlove RL; Nanas JN; Anderson JL
    Circulation; 1988 Aug; 78(2):286-95. PubMed ID: 2456167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorcainide infusion in the treatment of ventricular premature beats (VPB).
    Klotz U; Müller-Seydlitz PM; Heimburg P
    Eur J Clin Pharmacol; 1979 Aug; 16(1):1-6. PubMed ID: 499295
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
    Anderson JL; Anastasiou-Nana MI; Menlove RL; Moreno FL; Nanas JN; Barker AH
    Circulation; 1990 Sep; 82(3):830-40. PubMed ID: 1697514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of pirmenol hydrochloride in suppressing high frequency ventricular ectopy: a placebo-controlled, double-blind, multicenter study.
    Báguena Candela J
    Am J Cardiol; 1987 Jun; 59(16):48H-52H. PubMed ID: 2438924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
    N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide dose-response relations in stable ventricular arrhythmias.
    Woosley RL; Siddoway LA; Duff HJ; Roden DM
    Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
    Liem LB; Clay DA; Franz MR; Swerdlow CD
    Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.
    Kostis JB; Krieger S; Moreyra A; Cosgrove N
    J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term antiarrhythmic therapy with cibenzoline.
    Mohiuddin SM; Hilleman DE; Esterbrooks D; Mooss AN; Stengel LA
    J Clin Pharmacol; 1987; 27(5):400-6. PubMed ID: 3693585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of malignant ventricular arrhythmia--experience with lorcainide.
    Podrid PJ; Lown B
    Am J Cardiol; 1984 Aug; 54(4):29B-36B. PubMed ID: 6465044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.